The Centers for Medicare & Medicaid Services (CMS) and its measure developer are seeking nominations for the Clinician Expert Workgroup that will provide input on the development of the Breast Cancer Screening episode-based cost measure for potential use in the Quality Payment Program (QPP). The nomination period opened on June 2, and interested clinicians are invited to submit nominations between now and June 23, 2025, at 11:59 p.m. ET, with the first workgroup meeting scheduled to occur in July 2025.

Clinicians interested in joining the Wave 7 Breast Cancer Screening workgroup may submit their nomination through the web-based nomination form.

Please note, CMS is also hosting the OP-39 Re-Specification TEP, which is working on facility-based quality measurement for breast cancer screening concurrent to this cost measure development cycle. There are no restrictions to participating in this Clinician Expert Workgroup if you are also interested in participating in the OP-39 Re-Specification TEP. These are clinically related topics; however, the clinician expert panels will be developing different types of measures (cost vs quality) for different settings (clinician/groups vs facilities).

For more information, please refer to the Call for Nominations posting website or the nomination form. Should you have any further questions, please contact the Acumen PCMP Workgroup Support Team at pcmp-workgroup-support@acumenllc.com.